News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
Biotech/Pharma - Events
Rexahn Pharmaceuticals, Inc. (RNN) To Present At 13th Annual Biotechnology Industry Organization (BIO) Investor Forum 9/30/2014
Overview Of MediciNova, Inc.''s Clinical Trial Of MN-166 (Ibudilast) In ALS To Be Presented At The 13th Annual NEALS Meeting 9/30/2014
Heat Biologics To Present At The 13th Annual Biotechnology Industry Organization (BIO) Investor Forum In San Francisco On Tuesday, October 7, 2014 9/30/2014
Matinas BioPharma To Present At The 13th Annual Biotechnology Industry Organization (BIO) Investor Forum On Wednesday, October 8, 2014 9/30/2014
Relypsa, Inc. (RLYP) To Present At The 13th Annual Biotechnology Industry Organization (BIO) Investor Forum 9/30/2014
Blueprint Medicines To Present At 13th Annual Biotechnology Industry Organization (BIO) Investor Forum 9/30/2014
Arno Therapeutics To Present At The 13th Annual Biotechnology Industry Organization (BIO) Investor Forum 9/30/2014
Biocept, Inc. (BIOC) To Present At The 13th Annual Biotechnology Industry Organization (BIO) Investor Forum 9/30/2014
Amicus Therapeutics, Inc. (FOLD) To Present At Leerink Partners Rare Disease Roundtable 9/30/2014
GenSpera To Present Lead Drug Candidate Mipsagargin At 2nd Global Life Sciences Conference In Warsaw, Poland 9/30/2014
Organovo Selected As A Finalist In 27th Annual CONNECT Most Innovative New Product Awards 9/30/2014
Pfizer (PFE), Abbott Laboratories (ABT) Snubbed By Indian PM After Generics Scuffle 9/30/2014
Navidea Biopharmaceuticals (NAVB) To Participate In The BTIG Emerging Technologies In Healthcare Diagnostics Investor Conference September 30th 9/30/2014
Cortendo AB To Present At The Epic Biotech Conference In London On October 2, 2014 9/30/2014
Sophiris Bio Inc. (SPHS) To Present At The 13th Annual Biotechnology Industry Organization (BIO) Investor Forum 9/30/2014
NephroGenex (NRX) To Present At The 13th Annual Biotechnology Industry Organization (BIO) Investor Forum 9/30/2014
Specialty Vaccine Company PaxVax, Inc. To Present At 13th Annual Biotechnology Industry Organization (BIO) Investor Forum 9/30/2014
Fibrocell Science, Inc. To Present At 2014 Stem Cell Meeting On The Mesa 9/30/2014
Zoetis (ZTS) To Host Webcast And Conference Call On Third Quarter 2014 Financial Results 9/30/2014
Bio-Path Holdings To Present At The 13th Annual Biotechnology Industry Organization (BIO) Investor Forum 9/30/2014
Catabasis Pharmaceuticals, Inc. Management To Present At October Investor Conferences 9/30/2014
Mucosis B.V. Presents Infectious Diseases Vaccines Pipeline Update At Sachs Associates - Bloomberg L.P. 14th Annual Biotech In Europe Forum 9/30/2014
Karolinska Development AB Invites To A Capital Markets Day And Brings The Third Quarter Report Forward 9/30/2014
GlobeImmune, Inc. (GBIM) To Present At The 13th Annual BioInvestor Forum 9/30/2014
Rho Highlights Risk-Based Monitoring And History Of Success At 6th Annual OCT New England Conference 9/30/2014
Georgia Bio And UCB To Host Parkinson’s Gala Benefitting The National Parkinson Foundation, Wilkins Parkinson's Foundation 9/30/2014
MiMedx To Present At The Stem Cell Meeting On The Mesa 9/29/2014
Seattle Genetics, Inc. (SGEN) To Host Conference Call And Webcast On September 29, 2014 Regarding Top-Line Data From ADCETRIS® (brentuximab vedotin) Phase 3 AETHERA Clinical Trial 9/29/2014
Helix Biopharma (CC:HBP) To Present At The 2nd Global Life Sciences Conference In Warsaw, Poland 9/29/2014
AbbVie (ABBV) Presents Results From Multiple Studies Of Investigational Compound Veliparib In Patients With Non-Small Cell Lung Cancer At The European Society For Medical Oncology Annual Congress 9/29/2014
Cytogel Pharma (Cytogel) Announces Presentation At The 8th Annual Pain And Migraine Therapeutics Summit In Boston On September 24, 2014, Novel Mu Opioid Mechanisms For The Potent Analgesic Cyt-1010 Distinguish It From Morphine 9/29/2014
Compugen Ltd. (CGEN) Announces Presentations Of Results For CGEN-15001 Supporting Immune Tolerance Induction 9/29/2014
RXi Pharmaceuticals (RXII) To Present At The 13th Annual Biotechnology Industry Organization (BIO) Investor Forum 9/29/2014
MEDTEC Ireland Returns to Galway This October 9/29/2014
OncoMed Pharmaceuticals, Inc. (OMED) Presents Encouraging Data From Clinical Trials Of Tarextumab (Anti-Notch2/3) In Pancreatic Cancer And Small Cell Lung Cancer At The ESMO 2014 Congress 9/29/2014
Applied Genetic Technologies Corporation Leadership To Present At Upcoming Healthcare Conferences 9/29/2014
Cortendo AB To Present At The 14th Annual BIOTECH In Europe Forum In Basel September 30, 2014 9/29/2014
Acceleron Pharma To Webcast Presentation At Leerink Partners Rare Disease Roundtable 9/29/2014
Dicerna Pharmaceuticals (DRNA) To Present At Three Upcoming Investor Conferences 9/29/2014
Catabasis Pharmaceuticals, Inc. To Present At International Congress Of The World Muscle Society 9/29/2014
Novogen Limited (NVGN) Release: Graham Kelly Phd, CEO & Chairman Attended The Rodman & Renshaw 16th Annual Global Investment Conference 9/29/2014
Ocera Therapeutics, Inc. (OCRX) Therapeutics To Present At 13th Annual Biotechnology Industry Organization (BIO) Investor Forum 9/29/2014
Athersys, Inc. (ATHX) To Present At 2014 Stem Cell Meeting On The Mesa 9/29/2014
Clinovo Presents And Sponsors Leading Conferences In September, Including The Annual “Society For Clinical Data Management” (SCDM) Conference 9/29/2014
Galena Biopharma  (GALE) Announces Release Of Special Committee Report And Hosting Of A Conference Call To Provide A Corporate Update 9/26/2014
Karyopharm Therapeutics (KPTI) To Host Conference Call To Discuss Selinexor (KPT-330) Data Presented At ESMO 2014 9/26/2014
Washington Biotechnology & Biomedical Association Release: Biotech Pioneer To Keynote Governor’s Life Sciences Summit & Annual Meeting October 24 9/26/2014
Ignyta (RXDX) To Present At Livingston Securities Life Science Stakeholders Summit 9/26/2014
Agios Pharmaceuticals (AGIO) To Present Clinical Data From AG-120 Ongoing Phase 1 Study In Hematologic Malignancies At EORTC-NCI-American Association for Cancer Research 2014 9/26/2014
Rheonix, Inc. To Present At Inaugural BTIG Emerging Technologies In Healthcare Diagnostics Symposium 9/26/2014
Presented By The Japanese Cancer Association And Debiopharm Group™, The ‘JCA-Mauvernay Award 2014’ Goes To Doctors Hara And Shibata 9/26/2014
Lpath, Inc. (LPTN) To Present At The 13th Annual Biotechnology Industry Organization (BIO) Investor Forum 9/26/2014
CytRx Corporation (CYTR) Updates Presentation Time At Biocentury's 2014 Newsmakers In The Biotech Industry Conference 9/26/2014
ImmunoCellular Therapeutics, Ltd (IMUC) To Present At Livingston Securities Conference On October 1, 2014 9/26/2014
MediGene AG (MDGEF.PK) To Present At PIVAC Conference Rome 9/25/2014
Radius (RDUS) To Present At Biocentury Newsmakers In The Biotech Industry Conference 9/25/2014
Molecular Templates Inc. Presents Preclinical Data On CD38-Targeted Engineered Toxin Body (ETB) At The American Association For Cancer Research Special Conference, Hematologic Malignancies: Translating Discoveries To Novel Therapies 9/25/2014
VBI To Present At The CMV Public Health & Policy Conference 9/25/2014
TRACON Pharmaceuticals, Inc. Announces Results From Clinical Trials Of TRC105 In Patients With Ovarian Cancer To Be Presented At The 2014 Annual Meeting Of The European Society For Medical Oncology 9/25/2014
Hyperion Therapeutics (HPTX) To Present At The Leerink Rare Disease Roundtable 9/25/2014
Zafgen (ZFGN) To Present At 2014 Leerink Partners Rare Disease Roundtable 9/25/2014
Aegerion Pharmaceuticals, Inc. (AEGR)Announces Presentation At The Leerink Rare Disease Roundtable 9/25/2014
SAGE Therapeutics To Participate In The 2014 Leerink Partners Rare Disease Roundtable 9/25/2014
Helsinn Announces That Pivotal Phase 3 Trial Data For Anamorelin In ROMANA 1 And 2 Studies In Non-Small Cell Lung Cancer Patients With Anorexia-Cachexia Will Be Presented At The 38th European Society For Medical Oncology (ESMO) Congress In 2014 9/25/2014
uniQure To Present At The Leerink Partners Rare Disease Roundtable Conference 9/25/2014
Amgen (AMGN) To Host Summary Webcast Of Kyprolis® (Carfilzomib) For Injection Data Presented At The European Society For Medical Oncology (ESMO) 2014 Congress 9/25/2014
Marinus Pharmaceuticals (MRNS) To Present At The 21st Annual Biocentury Newsmakers Conference On Friday, September 26, 2014 9/25/2014
ProSensa Holding N.V. (RNA) To Present At Upcoming Conferences 9/25/2014
NovoCure Ltd. Announces Recurrent Glioblastoma Patient Registry Dataset (PRide) To Be Presented At ESMO And EANO 2014 9/25/2014
Simbec-Orion To Attend ESMO 2014 Congress 9/25/2014
Alnylam Pharmaceuticals (ALNY) To Webcast Presentation At Leerink Partners Rare Disease Roundtable 9/25/2014
NPS Pharmaceuticals, Inc. (NPSP) To Present At Leerink Partners Rare Disease Roundtable 9/25/2014
Sarepta Therapeutics (SRPT) To Present At Leerink Partners Rare Disease Roundtable 9/25/2014
Dyax Corp. (DYAX) To Participate In The Leerink Partners Rare Disease Roundtable 9/25/2014
Osiris Therapeutics, Inc. (OSIR) To Present At The 2014 Stem Cell Meeting On The Mesa 9/25/2014
Epizyme (EPZM) To Present at Upcoming Events In October 9/25/2014
Fibrocell Science, Inc. To Present At BioCentury NewsMakers Of The Biotech Industry Conference 9/25/2014
PTC Therapeutics, Inc. (PTCT) To Present At The Leerink Partners Rare Disease Roundtable 9/25/2014
What Happened At BioPharm America 2014? 9/24/2014
Lipocine Inc. (LPCN) To Host Conference Call And Webcast To Discuss Top-Line Results From The Phase 3 Study Of LPCN 1021 9/24/2014
Hyperion Therapeutics (HPTX) To Host Analyst Day September 30, 2014 9/24/2014
Agios Pharmaceuticals (AGIO) To Present At The 2014 Leerink Partners Rare Disease Roundtable 9/24/2014
GW Pharmaceuticals To Present At The Leerink Rare Disease Roundtable 2014 9/24/2014
Ultragenyx Pharmaceuticals (RARE) To Present At The Leerink Partners Rare Disease Roundtable 9/24/2014
MedNet Solutions - Proud To Sponsor The SCDM 2014 Annual Conference 9/24/2014
ESMO 2014 To Feature New Oncology Data From Across Bayer HealthCare Pharmaceuticals (BAYA.F) Franchise 9/24/2014
Data From Study Of Champions Oncology, Inc. (CSBR) Tumorgrafts To Be Presented At European Society For Medical Oncology (ESMO) 2014 Congress 9/24/2014
Isis Pharmaceuticals, Inc. (ISIS) To Present At The Leerink Partners Rare Disease Roundtable 9/24/2014
MediGene AG (MDGEF.PK) To Present At Baader Investment Conference Munich 9/24/2014
Latest Discoveries In Oncology to be Presented At ESMO 2014 9/24/2014
Audentes Therapeutics To Present At The Leerink Partners Rare Disease Roundtable 9/24/2014
Insmed Incorporated (INSM) To Participate In Leerink Partners’ Rare Disease Roundtable 9/24/2014
Transgenomic, Inc. (TBIO) To Present At BTIG Emerging Technologies In Healthcare Diagnostics Conference 9/24/2014
Arch Therapeutics Co-Founder Rutledge Ellis-Behnke To Speak At 12th International Conference On Neuroprotective Agents On September 29 9/24/2014
Provectus Biopharmaceuticals Inc.’ PV-10 Clinical Data On Melanoma Now Available For European Society For Medical Oncology 2014 Congress 9/24/2014
Brand India Pharma: The Responsible Healthcare Provider At CPhI Worldwide 2014 9/24/2014
Clinovo Sponsors And Presents At Pharmaceutical Users Software Exchange (PhUSE) SDE In San Francisco 9/24/2014
BioCrea Announces Upcoming Presentations At Leading International Conferences 9/24/2014
Horizon Pharma plc.  (HZNP) To Host Friedreich's Ataxia Analyst Day On October 13, 2014 9/24/2014
Endocyte, Inc. (ECYT) Announces Late-Breaking Abstract Presentation At The European Society For Medical Oncology (ESMO) Conference 9/23/2014
BioMarin Pharmaceutical Inc. (BMRN) To Attend Upcoming Investor Conferences 9/23/2014
Raptor Pharmaceutical Inc. (RPTP) To Present At Leerink Rare Disease Roundtable 9/23/2014
Rexahn Pharmaceuticals, Inc. (RNN)To Present At The 14th Annual Biotech In Europe Investor Forum For Global Partnering And Investment In Basel, Switzerland 9/23/2014
Y-PRIME To Participate In IRT 2014 9/23/2014
Esperion Therapeutics, Inc. (ESPR)To Present At BioCentury’s Newsmakers In The Biotech Industry Conference 9/23/2014
Syros Pharmaceuticals Presents Research On Gene Control In Acute Myeloid Leukemia At AACR Hematologic Malignancies Meeting 9/23/2014
Liquidia Technologies Inc. To Present At Nano Manufacturing 2014 Conference 9/23/2014
Eagle Pharmaceuticals (EGRX) To Present At 21st Annual NewsMakers In The Biotechnology Industry Investment Conference 9/23/2014
Liquidia Technologies Inc. To Present Innovations In Nanofabrication Of Vaccine Formulations 9/23/2014
Neovacs SA Will Attend Société Générale's "Healthcare & Biotechnology Conference" For The Second Time On 24 September 2014 9/23/2014
Provectus Biopharmaceuticals Inc.’ Intralesional Pv-10 And Co-Inhibitory Blockade Data To Be Presented At SITC 29th Annual Meeting 9/23/2014
Horizon Pharma plc.  (HZNP) To Present At The 21st Annual NewsMakers In The Biotech Industry Conference 9/23/2014
AbbVie (ABBV) To Present Clinical Study Data On Potential New Oncology Medicines At The 2014 European Society Of Medical Oncology Annual Meeting 9/22/2014
CytRx Corporation (CYTR) Announces Presentation of Aldoxorubicin Global Phase 3 Soft Tissue Sarcomas And Global Phase 2b Small Cell Lung Cancer Trial Designs At ESMO 2014 Congress 9/22/2014
Agile Therapeutics, Inc. To Present At The 21st Annual Biocentury Newsmakers Conference 9/22/2014
GlycoMimetics, Inc. (GLYC) To Present At Biocentury's 21st Annual Newsmakers In The Biotech Industry Conference 9/22/2014
Repros Therapeutics Inc. (RPRX) Gives Update On Androxal® With Respect To Recent FDA Advisory Panel Outcome And Announces Upcoming Presentation At Biocentury 9/22/2014
Arena Pharmaceuticals, Inc. (ARNA) To Present At The NewsMakers In The Biotech Industry Conference 9/22/2014
Kibow Biotech, Inc. Presents Renadyl Story About Kidney Function At Harvard Medical School Probiotics Symposium 9/22/2014
Arrowhead Research Corporation (ARWR) To Present At Biocentury’s NewsMakers In The Biotech Industry Conference 9/22/2014
EPIRUS Biopharmaceuticals To Present At NewsMakers In The Biotech Industry Conference 9/22/2014
Systech To Host Serialization Webinar For The Pharmaceutical Industry 9/22/2014
TxCell To Participate At Société Générale Healthcare & Biotechnology Conference, Paris 9/22/2014
Alnylam Pharmaceuticals (ALNY) To Webcast Presentation At 21st Annual NewsMakers In The Biotech Industry Conference 9/22/2014
ContraFect Corporation (CFRXU) To Present At BioCentury's 21st Annual NewsMakers In The Biotech Industry Conference 9/22/2014
SYGNIS Pharma AG’ New TthPrimPol Polymerase Took Centre Stage At Zing DNA Polymerases Conference 2014 9/22/2014
Onxeo Attends InvestorDagen 2014, The Largest Danish Private Investor Event 9/22/2014
Cyclacel Pharmaceuticals, Inc. (CYCC) To Present At Biocentury's Newsmakers In The Biotech Industry Conference 9/19/2014
Merrimack Pharmaceuticals Inc. (MACK)To Present Clinical And Biomarker Data On Novel Antibody Therapeutics At The ESMO 2014 Congress 9/19/2014
Celator Pharmaceuticals, Inc. To Present At Biocentury's 21st Annual Newsmakers In The Biotech Industry Conference 9/19/2014
Argos Therapeutics, Inc. (ARGS) To Present At The 21st Annual Biocentury Newsmakers Conference 9/19/2014
TONIX Pharmaceuticals, Inc. To Present At The Biocentury Newsmakers Conference 9/19/2014
BioSpecifics Technologies Corporation (BSTC) Announces New MULTICORD And Retreatment Data For XIAFLEX® For Dupuytren's Contracture Presented At American Society For Surgery Of The Hand Annual Meeting 9/19/2014
CytRx Corporation (CYTR) To Present At Biocentury's 2014 Newsmakers In The Biotech Industry Conference 9/19/2014
Pfenex Inc. (PFNX) To Present At Upcoming Industry Conference On September 26 9/19/2014
BioSpecifics Technologies Corporation (BSTC) To Present At The 21st Annual Biocentury Newsmakers In The Biotech Industry Conference 9/19/2014
DiaGenic ASA – Notice Of Extraordinary General Meeting 9/19/2014
Biotechnology Industry Organization (BIO) Announces Breakout Program Speakers For Pacific Rim Summit On Industrial Biotechnology 9/19/2014
Genocea Biosciences To Present At The 21st Annual NewsMakers In The Biotech Industry Conference 9/19/2014
Cloud Pharmaceuticals Announces Partnering Sessions And Presentation Schedule 9/19/2014
ImmuCell (ICCC) Participating At Multiple Dairy And Beef Industry Events Throughout September 2014 9/19/2014
SciClone Pharmaceuticals, Inc. (SCLN) To Present At Biocentury Newsmakers In The Biotech Industry Conference On September 26, 2014 9/19/2014
In Silico Drug Discovery Conference Announces Speakers And Topics 9/19/2014
Pathway Genomics Corporation Announces Commitment To Free The Data Movement At NSGC Conference 9/18/2014
Capricor Therapeutics, Inc. Presents Safety And Preliminary Efficacy Results From ALLSTAR Phase I Clinical Trial At TCT 2014 9/18/2014
Pain Therapeutics (PTIE) To Present At The Biocentury Newsmakers Conference On Friday, September 26th 9/18/2014
Cerulean Pharma Inc. (CERU) To Present At Biocentury's Newsmakers In Biotechnology Conference 9/18/2014
Rebiotix Release: PUNCH CD Study Drug Targeting Recurrent C. Difficile Infection To Be Presented At IDWeek 2014 9/18/2014
Prime Therapeutics' Wickersham Delivers Keynote At Managed Markets Summit 9/18/2014
In Silico Drug Discovery Conference Announces Speakers And Topics 9/18/2014
Auxilium Pharmaceuticals (AUXL) Presents XIAFLEX (CCH) Data From MULTICORD And Retreatment Studies At The ASSH Annual Meeting 9/18/2014
Inovio Pharmaceuticals (INO) To Present At Upcoming Investor Conferences 9/18/2014
RXi Pharmaceuticals (RXII) To Present At The 7th Annual Biopharm America Conference 9/18/2014
UBM Canon Release: Pharmapack North America Show To Relaunch In 2015 9/18/2014
Relypsa, Inc. (RLYP) To Present At Newsmakers In The Biotech Industry 9/18/2014
Trends In Regulatory Convergence And Global Life Sciences Compliance To Be Key Topics Of Discussion At Maetrics' Booth #527 At Regulatory Affairs Professionals Conference (RAPS) 9/18/2014
Biothera To Present At European Society Of Medical Oncology 2014 Congress 9/18/2014
Acucela Inc. To Present At The Biocentury Newsmakers In The Biotech Industry Conference 9/18/2014
TetraPhase Pharmaceuticals To Present At Biocentury’s 2014 Newsmakers In The Biotech Industry Conference 9/18/2014
Arno Therapeutics' Executive Selected To Chair World CDx Boston 2014 9/18/2014
Cerulean Pharma Inc. (CERU) To Present At Biocentury's Newsmakers In Biotechnology Conference 9/18/2014
Bacterin International, Inc. To Present At The Singular Research 9th Annual Best Of The Uncovereds Conference 9/18/2014
Mologen AG (MOLGF.PK): Three Poster Presentations At ESMO 2014 Congress 9/18/2014
GlobeImmune, Inc. (GBIM) To Present At The 21st Annual NewsMakers In The Biotechnology Industry Investment Conference 9/18/2014
Omni Bio Pharmaceutical To Present At 7th Annual BioPharm America Conference 9/18/2014
Clinovo Sponsors And Presents At Pharmaceutical Users Software Exchange (PhUSE) SDE In San Francisco 9/18/2014
Novadaq Corp. To Host Analyst & Investor Day On November 17, 2014 9/17/2014
Cara Therapeutics, Inc. (CARA) To Sponsor Symposium At American Academy Of Pain Management 2014 Annual Clinical Meeting 9/17/2014
Orexigen Therapeutics, Inc. (OREX) To Present At The Bank of America (BAC) Merrill Lynch Global Healthcare Conference 9/17/2014
Neuraltus Pharmaceuticals, Inc.' ALS Treatment Candidate, NP001, Highlighted At ALS Research Group Summit 9/17/2014
Intarcia Therapeutics, Inc. Reveals New Insights At EASD Meeting Characterizing The Burden Of Poor Control And Non-Adherence To Anti-Diabetic Therapies 9/17/2014
Exelixis, Inc. (EXEL) Announces Cobimetinib Phase 3 coBRIM Results To Be Presented At ESMO 2014 Congress 9/17/2014
American Academy of Ophthalmology's Annual Meeting To Showcase Latest in Eye Care Research, Technology, Clinical Education and Legislation 9/17/2014
BioClinica, Inc. To Present At 20th Annual SCDM Conference 9/17/2014
Bayer Corporation (BAY) To Present Data On Hemophilia Research At NHF In Washington, D.C. 9/17/2014
Catalent, Inc. To Present At The Deutsche Bank (DB) 2014 Leveraged Finance Conference 9/17/2014
KineMed, Inc. To Showcase Advances In Dynamic Proteomic Markers Of Neurodegenerative Disease At The 8th Annual Neurodegenerative Conditions Research & Development Conference 9/17/2014
IntelGenx Corp. To Present At Singular Research 9th Annual Best Of The Uncovereds Conference 9/17/2014
Roper Industries To Present At Citi's 2014 Industrials Conference 9/17/2014
Momenta Pharmaceuticals, Inc. (MNTA) To Webcast Presentation At Biocentury's Newsmakers In The Biotech Industry Conference 9/17/2014
OncoMed Pharmaceuticals, Inc. (OMED) To Present New And Emerging Data From Demcizumab (Anti-DLL4, OMP-21M18) And Tarextumab (Anti-Notch2/3, OMP-59R5) Clinical Studies At The European Society For Medical Oncology 2014 Congress 9/17/2014
Roche (RHHBY) To Present Latest Oncology Advances During ESMO 2014 Congress 9/17/2014
Oxford Gene Technology Ltd. Presents The Latest In Tumour Screening At BSGM 9/17/2014
Ignyta (RXDX) To Participate In Precision Medicine Panel Discussions With Other Thought Leaders 9/17/2014
Clinical Data On AVEO Oncology (AVEO)’s Ficlatuzumab And Tivozanib To Be Presented At The ESMO 2014 Congress 9/17/2014
Arch Therapeutics Co-Founder Rutledge Ellis-Behnke To Speak At 12th Annual Current Issues In Medicine, Biotech And Pharma Conference On September 18 9/17/2014
Boston Therapeutics, Inc. To Present At National Investment Banking Conference On September 16, 2014 9/17/2014
Event Report: Cellectis (ALCLS) R&D/ Analyst Day 9/17/2014
Boston Therapeutics, Inc. To Present Findings Of BTI-320 As Therapy For Glycemic Control At 50th Annual Meeting Of European Association For The Study Of Diabetes 9/17/2014
ZS Pharma (ZSPH) To Present At The 21st Annual Biocentury Newsmakers Conference 9/17/2014
New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density 9/16/2014
Heptares To Present On Structure-Based Drug Design Using G Protein-Coupled Receptors At Inaugural Chemistry & Engineering News Virtual Symposium 9/16/2014
Henry Schein, Inc. (HSIC) To Present At The Leerink Partners Services Roundtable 9/16/2014
Imprimis Pharmaceuticals (immy) To Present At Craig-Hallum Alpha Select Conference 9/16/2014
IMRIS CEO Jay D. Miller To Present At The 5th Annual Craig-Hallum Alpha Select Conference 9/16/2014
LifeScience Alley® 30th Anniversary Conference To Feature Global Healthcare Leaders 9/16/2014
Osiris Therapeutics, Inc. (OSIR) Release: Grafix® Featured In Plenary Session Oral Presentation At The Joint Annual Meeting Of The Eastern And New England Vascular Societies 9/16/2014
LabCorp/ARCA biopharma GENETIC-AF Poster Presented At The 18th Annual Scientific Meeting Of The Heart Failure Society Of America 9/16/2014
New Data Supporting VBI's Prophylactic Cytomegalovirus (CMV) Vaccine Candidate (VBI-1501A) Presented At The 54th ICAAC Conference In Washington, D.C. 9/16/2014
Ocular Therapeutix, Inc. (OCUL) To Present At The 21st Annual NewsMakers In The Biotech Industry Investment Conference On Friday, September 26 9/16/2014



//-->